← Back to Search

Behavioral Intervention

Information Access for Birth Control

N/A
Recruiting
Led By Eleanor Schwarz, MD, MS
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 month follow-up
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if providing information to women who want to avoid pregnancy about tubal sterilization and long-acting reversible contraceptives helps them access contraceptives better. Participants will fill out

Who is the study for?
This trial is for women who do not wish to become pregnant in the future. Participants should be considering their options for permanent contraception and willing to complete surveys about their perceptions of contraceptive access after using educational websites.
What is being tested?
The study tests if a new website with patient-centered information on tubal sterilization versus long-acting reversible contraceptives (LARC) affects women's views on contraceptive access, compared to an existing Planned Parenthood website.
What are the potential side effects?
There are no direct physical side effects from participating in this trial as it involves gathering information from web-based resources rather than medical interventions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Perceived Access to Long Acting Contraceptives
Secondary study objectives
Consumer Assessment of Healthcare Providers and Systems
Knowledge of Long-Acting Contraceptives
Patients' Perceived Efficacy in Patient-Physician Interactions (PEPPI)
+3 more
Other study objectives
Suggestions for how to improve web-based resources for people considering permanent contraception.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Comparative information on tubal sterilization and other long-acting contraceptivesExperimental Treatment1 Intervention
A new website comparing tubal sterilization to vasectomy and long-acting reversible contraceptives
Group II: Information on tubal sterilizationActive Control1 Intervention
Participants will be shown an existing web page developed by Planned Parenthood for people considering tubal sterilization

Find a Location

Who is running the clinical trial?

Agency for Healthcare Research and Quality (AHRQ)FED
408 Previous Clinical Trials
6,792,924 Total Patients Enrolled
Essential Access HealthOTHER
6 Previous Clinical Trials
2,520 Total Patients Enrolled
University of California, San FranciscoLead Sponsor
2,593 Previous Clinical Trials
14,887,300 Total Patients Enrolled
Eleanor Schwarz, MD, MSPrincipal InvestigatorUniversity of California, San Francisco
~162 spots leftby Apr 2025